Cabaletta Bio Inc
NASDAQ:CABA
Income Statement
Earnings Waterfall
Cabaletta Bio Inc
Income Statement
Cabaletta Bio Inc
| Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||||||||||
| Operating Expenses |
(13)
|
(15)
|
(19)
|
(23)
|
(27)
|
(30)
|
(34)
|
(36)
|
(39)
|
(42)
|
(46)
|
(50)
|
(52)
|
(52)
|
(54)
|
(58)
|
(61)
|
(68)
|
(75)
|
(86)
|
(100)
|
(115)
|
(125)
|
(134)
|
(149)
|
(163)
|
|
| Selling, General & Administrative |
(4)
|
(5)
|
(7)
|
(9)
|
(11)
|
(12)
|
(12)
|
(12)
|
(13)
|
(13)
|
(14)
|
(14)
|
(15)
|
(15)
|
(15)
|
(16)
|
(16)
|
(17)
|
(19)
|
(21)
|
(24)
|
(25)
|
(28)
|
(30)
|
(31)
|
(31)
|
|
| Research & Development |
(9)
|
(10)
|
(12)
|
(14)
|
(16)
|
(19)
|
(21)
|
(23)
|
(26)
|
(28)
|
(32)
|
(35)
|
(37)
|
(37)
|
(39)
|
(43)
|
(45)
|
(50)
|
(55)
|
(65)
|
(77)
|
(89)
|
(97)
|
(104)
|
(118)
|
(132)
|
|
| Operating Income |
(13)
N/A
|
(15)
-15%
|
(19)
-25%
|
(23)
-21%
|
(27)
-19%
|
(30)
-13%
|
(34)
-11%
|
(36)
-5%
|
(39)
-8%
|
(42)
-8%
|
(46)
-11%
|
(50)
-7%
|
(52)
-4%
|
(52)
0%
|
(54)
-5%
|
(58)
-7%
|
(61)
-5%
|
(68)
-11%
|
(75)
-10%
|
(86)
-15%
|
(100)
-17%
|
(115)
-14%
|
(125)
-9%
|
(134)
-7%
|
(149)
-11%
|
(163)
-9%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||
| Interest Income Expense |
1
|
1
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
3
|
5
|
7
|
9
|
10
|
10
|
9
|
7
|
6
|
4
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Total Other Income |
(6)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
|
| Pre-Tax Income |
(18)
N/A
|
(13)
+26%
|
(17)
-26%
|
(21)
-23%
|
(26)
-23%
|
(29)
-15%
|
(33)
-13%
|
(36)
-7%
|
(39)
-8%
|
(42)
-8%
|
(46)
-11%
|
(50)
-7%
|
(51)
-4%
|
(51)
+0%
|
(53)
-4%
|
(56)
-5%
|
(57)
-3%
|
(62)
-9%
|
(68)
-8%
|
(77)
-14%
|
(90)
-17%
|
(104)
-16%
|
(116)
-11%
|
(127)
-9%
|
(144)
-14%
|
(159)
-10%
|
|
| Net Income | |||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(18)
|
(13)
|
(17)
|
(21)
|
(26)
|
(29)
|
(33)
|
(36)
|
(39)
|
(42)
|
(46)
|
(50)
|
(51)
|
(51)
|
(53)
|
(56)
|
(57)
|
(62)
|
(68)
|
(77)
|
(90)
|
(104)
|
(116)
|
(127)
|
(144)
|
(159)
|
|
| Net Income (Common) |
(23)
N/A
|
(19)
+20%
|
(22)
-19%
|
(21)
+6%
|
(26)
-23%
|
(29)
-15%
|
(33)
-13%
|
(36)
-7%
|
(39)
-8%
|
(42)
-8%
|
(46)
-11%
|
(50)
-7%
|
(51)
-4%
|
(51)
+0%
|
(53)
-4%
|
(56)
-5%
|
(57)
-3%
|
(62)
-9%
|
(68)
-8%
|
(77)
-14%
|
(90)
-17%
|
(104)
-16%
|
(116)
-11%
|
(127)
-9%
|
(144)
-14%
|
(159)
-10%
|
|
| EPS (Diluted) |
-1.03
N/A
|
-0.83
+19%
|
-0.93
-12%
|
-0.92
+1%
|
-1.11
-21%
|
-1.26
-14%
|
-1.44
-14%
|
-1.48
-3%
|
-1.55
-5%
|
-1.93
-25%
|
-1.8
+7%
|
-1.71
+5%
|
-1.76
-3%
|
-1.78
-1%
|
-1.81
-2%
|
-1.57
+13%
|
-1.46
+7%
|
-1.42
+3%
|
-1.65
-16%
|
-1.6
+3%
|
-1.83
-14%
|
-2.1
-15%
|
-2.34
-11%
|
-2.49
-6%
|
-2.33
+6%
|
-1.55
+33%
|
|